Cargando…

Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl

In accordance with Article 31 of Regulation (EC) No 178/2002, the European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 MRL reviews under Regulation (EC) No 396/2005 for the following subs...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186194/
https://www.ncbi.nlm.nih.gov/pubmed/37200853
http://dx.doi.org/10.2903/j.efsa.2023.8013
_version_ 1785042514348081152
collection PubMed
description In accordance with Article 31 of Regulation (EC) No 178/2002, the European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 MRL reviews under Regulation (EC) No 396/2005 for the following substances/commodity combinations: 2,4‐DB on products of animal origin; iodosulfuron‐methyl on linseeds and maize; mesotrione on sugar canes; methoxyfenozide on aubergines and products of animal origin and pyraflufen‐ethyl on hops. EFSA prepared a statement containing a final conclusion on the completeness of the data necessary to support the existing tentative maximum residue levels (MRLs) and indications to risk managers whether or not the tentative MRLs currently established by Regulation (EC) No 396/2005 could be maintained. The statement was circulated to Member States for consultation via a written procedure before finalisation.
format Online
Article
Text
id pubmed-10186194
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101861942023-05-17 Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl EFSA J Statement In accordance with Article 31 of Regulation (EC) No 178/2002, the European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 MRL reviews under Regulation (EC) No 396/2005 for the following substances/commodity combinations: 2,4‐DB on products of animal origin; iodosulfuron‐methyl on linseeds and maize; mesotrione on sugar canes; methoxyfenozide on aubergines and products of animal origin and pyraflufen‐ethyl on hops. EFSA prepared a statement containing a final conclusion on the completeness of the data necessary to support the existing tentative maximum residue levels (MRLs) and indications to risk managers whether or not the tentative MRLs currently established by Regulation (EC) No 396/2005 could be maintained. The statement was circulated to Member States for consultation via a written procedure before finalisation. John Wiley and Sons Inc. 2023-05-16 /pmc/articles/PMC10186194/ /pubmed/37200853 http://dx.doi.org/10.2903/j.efsa.2023.8013 Text en © 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle Statement
Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
title Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
title_full Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
title_fullStr Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
title_full_unstemmed Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
title_short Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
title_sort lack of confirmatory data following article 12 mrl reviews for 2,4‐db, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
topic Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186194/
https://www.ncbi.nlm.nih.gov/pubmed/37200853
http://dx.doi.org/10.2903/j.efsa.2023.8013
work_keys_str_mv AT lackofconfirmatorydatafollowingarticle12mrlreviewsfor24dbiodosulfuronmethylmesotrionemethoxyfenozideandpyraflufenethyl